Pharma Journalist -

ReAlta Life Sciences announced that U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to PIC1-dPEG24 for the treatment of hypoxic-ischemic encephalopathy (HIE)…
Read More...

Italian-based Stevanato Group, a leading producer of glass primary packaging and provider of integrated capabilities for combination products and the US-based Pfeiffer Vacuum…
Read More...

Immix Biopharma, Inc., announced that the first patient in the USA was dosed successfully in its flagship phase 1b/2a clinical trial testing Imx-110 in patients with refractory solid…
Read More...

Rebiotix, a Ferring company, announced that it has completed enrollment of the pivotal Phase 3 clinical trial for RBX2660, an investigational therapy aimed at breaking the cycle of…
Read More...

BioMotiv and Bristol-Myers Squibb Company announced the launch of Anteros Pharmaceuticals, a biotechnology company focused on developing a new class of drugs for fibrotic and other…
Read More...

Regeneron Pharmaceuticals announced an expanded agreement with the U.S. Department of Health and Human Services (HHS) to develop new treatments combating the novel coronavirus,…
Read More...

Horses with severe equine asthma struggle to breath, even at rest. This week, the European Commission granted marketing authorization1 to Boehringer Ingelheim for the new Aservo…
Read More...

SMi Group Will Merge with Tech Briefs Media Group to Form SAE Media Group WARRENDALE, Pa. (February 3, 2020) – SAE International announced today the acquisition of SMi Group Ltd, a…
Read More...

Navrogen, Inc., a biopharmaceutical company specialized in developing therapies for cancer and immune-related disorders, and Levena Biopharma, a company specialized in developing…
Read More...

Teva Pharmaceutical Industries Ltd. announced positive results from two Phase 2/3 trials evaluating AJOVY (fremanezumab) in patients in Japan. AJOVY is under development in Japan by…
Read More...